Osler Diagnostics, with the slogan "Lab-quality diagnostics for anyone, anywhere, at any time," is a dynamic UK-based company in the Health Care and Life Sciences sectors. Founded in 2017, the company emerged from decades of research at the University of Oxford. Its flagship innovation, the Osler Origin, is a revolutionary "portable lab" device offering comprehensive, lab-quality diagnostics across various global healthcare settings.
The company is headquartered in Oxford, UK. It recently secured a substantial $85.00M Series C investment from prominent investors such as Lansdowne Partners, M&G Investments, Oxford Science Enterprises, and Braavos Investment Advisers on 07 November 2022. This funding underscores strong investor confidence in Osler’s potential to disrupt the diagnostics industry.
Overall, Osler Diagnostics represents an appealing opportunity for investors targeting high-impact innovations in global healthcare accessibility.